Evaluation of Parenteral Potassium Supplementation in Pediatric Patients.

Objective: The primary objective was to evaluate the effect of parenteral potassium chloride (KCl) supplementation on potassium (K) concentrations in a non-cardiac pediatric population. Secondary outcomes were to identify variables that may influence response to KCl supplementation (i.e., change in K concentration after KCl administration) and assess the incidence of hyperkalemia.

Methods: This single-center, retrospective study evaluated infants and children who received parenteral KCl supplementation of 0.5 or 1 mEq/kg between January 2017 and December 2019.

Results: The study included 102 patients with a median age of 1 year (IQR, 0.4-3.9) and weight of 9.1 kg (IQR, 4.9-14.2) who received 288 parenteral KCl administrations. One hundred seventy-three administrations were in the 1 mEq/kg group, and 115 administrations were in the 0.5 mEq/kg group. The median changes in K were 0.8 and 0.5 mEq/L in the 1 mEq/kg and 0.5 mEq/kg groups, respectively. Patients who had a repeat K concentration within 4 hours of the end of a 1 to 2-hour infusion had a higher median change in K compared with those who had a concentration drawn after this time frame (0.8 vs 0.6 mEq/L; p < 0.01).

Conclusions: There is a paucity of data on the correlation between parenteral KCl supplementation and change in K concentrations in pediatric patients. Our study demonstrated an association between KCl supplementation doses of 1 and 0.5 mEq/kg and changes in K of 0.8 and 0.5 mEq/L, respectively, in non-cardiac pediatric patients, with low observed incidence of hyperkalemia.